Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis: 1-Year Results From a Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension

被引：0

作者：

Maksymowych, Walter ^{[1
]}

van der Heijde, Desiree ^{[2
]}

Sieper, Joachim ^{[3
]}

van den Bosch, Filip ^{[4
]}

Kim, Tae-Hwan ^{[5
]}

Kishimoto, Mitsumasa ^{[6
]}

Ostor, Andrew ^{[7
,8
]}

Combe, Bernard ^{[9
]}

Sui, Yunxia ^{[10
]}

Wang, Xin ^{[10
]}

Chu, Alvina ^{[10
]}

Song, In-Ho ^{[10
]}

Deodhar, Atul ^{[11
]}

机构：

[1] CaRE Arthrit Ltd, Edmonton, AB, Canada

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Charite, Berlin, Germany

[4] Ghent Univ Hosp, Ghent, Belgium

[5] Hanyang Univ, Hosp Rheumat Dis, Seoul, South Korea

[6] St Lukes Int Hosp, Tokyo, Japan

[7] Cabrini Med Ctr, Malvern, Vic, Australia

[8] Monash Univ, Melbourne, Vic, Australia

[9] Hop Lapeyronie, Montpellier, France

[10] AbbVie Inc, N Chicago, IL USA

[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2021年 / 48卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1122 / 1122

页数：1

共 50 条

[1] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
Deodhar, Atul
van der Heijde, Desiree
Sieper, Joachim
Van den Bosch, Filip
Maksymowych, Walter
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Wang, Xin
Chu, Alvina D.
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[2] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
Deodhar, A.
Van der Heijde, D.
Sieper, J.
Van den Bosch, F.
Maksymowych, W. P.
Kim, T. H.
Kishimoto, M.
Ostor, A.
Combe, B.
Sui, Y.
Wang, X.
Chu, A.
Song, I. H.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 85 - 86
[3] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter P.
Sieper, Joachim
van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Chu, Alvina D.
Song, In-Ho
INTERNAL MEDICINE JOURNAL, 2022, 52 : 26 - 26
[4] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter
Sieper, Joachim
Van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Chu, Alvina D.
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1925 - 1928
[5] Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter P.
Sieper, Joachim
Van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew J.
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Wung, Peter K.
Song, In-Ho
RMD OPEN, 2022, 8 (02):
[6] Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension
Deodhar, Atul
van der Heijde, Desiree
Sieper, Joachim
Van den Bosch, Filip
Maksymowych, Walter P.
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Chu, Alvina D.
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2022, 74 (01) : 70 - 80
[7] Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
Bao, Chunde
Huang, Feng
Khan, Muhammad Asim
Fei, Kaiyin
Wu, Zhong
Han, Chenglong
Hsia, Elizabeth C.
RHEUMATOLOGY, 2014, 53 (09) : 1654 - 1663
[8] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
Xenofon Baraliakos
Désirée van der Heijde
Joachim Sieper
Robert D. Inman
Hideto Kameda
Yihan Li
Xianwei Bu
Anna Shmagel
Peter Wung
In-Ho Song
Atul Deodhar
Arthritis Research & Therapy, 25
[9] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
Baraliakos, Xenofon
van der Heijde, Desiree
Sieper, Joachim
Inman, Robert D.
Kameda, Hideto
Li, Yihan
Bu, Xianwei
Shmagel, Anna
Wung, Peter
Song, In-Ho
Deodhar, Atul
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[10] Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
van der Heijde, Desiree
Song, In-Ho
Pangan, Aileen
Deodhar, Atul
Van den Bosch, Filip
Maksymowych, Walter P.
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Everding, Andrea
Sui, Yunxia
Wang, Xin
Chu, Alvina D.
Sieper, Joachim
ARTHRITIS & RHEUMATOLOGY, 2019, 71

← 1 2 3 4 5 →